Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
about
cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytescGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac MyocytesThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Microvascular permeability.Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors.Clinical and molecular genetics of the phosphodiesterases (PDEs).Potential for pharmacological manipulation of human embryonic stem cells.Induction of signalling anergy via the T-cell receptor in cultured Jurkat T cells by pre-exposure to a filarial nematode secreted product.Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novelKinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP.Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle.cAMP Catalyzing Phosphodiesterases Control Cholinergic Muscular Activity But Their Inhibition Does Not Enhance 5-HT4 Receptor-Mediated Facilitation of Cholinergic Contractions in the Murine Gastrointestinal Tract.
P2860
Q24561615-E434DA97-8D92-435A-8824-FF1E5F9EAB46Q29306674-EEAA8648-0DAE-4D86-9405-A7CCEF377BD1Q30486745-3A0D0BB0-D770-407F-BBD2-D62423CACFACQ33676895-3EB4E9FB-B9D8-49C0-8971-14FB1D79CF64Q36334968-38663EE6-9E33-4890-A209-37673D74B76FQ36843124-D6909374-AC0A-4F71-9A17-9A0CE77538DEQ37178775-586865B9-5B3B-4CF3-A68F-9CA2177678CCQ37657841-32F9FF43-D04E-4C98-8399-C82E244E666DQ38003694-97767420-1735-4E33-B358-CD833CA9264BQ39048765-5EB4C4BF-84BD-4EA4-AB1E-BD67F144CD47Q39648017-0CC63565-9BC3-4F5F-A97E-90AEC31D1862Q42985106-3E6E763B-4AEF-45BA-A692-101E3C504788Q44163118-866CCEAD-E90E-4E96-9D67-F21766481348Q48254467-9D4C2774-BE1D-44C5-856C-D41536042BBCQ55257365-FED1F4DB-3220-4B4C-B117-5B8C0E98D68E
P2860
Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Rapid regulation of PDE-2 and ...... elective inhibitors erythro-9-
@nl
Rapid regulation of PDE-2 and ...... )-adenine (EHNA) and rolipram.
@en
type
label
Rapid regulation of PDE-2 and ...... elective inhibitors erythro-9-
@nl
Rapid regulation of PDE-2 and ...... )-adenine (EHNA) and rolipram.
@en
prefLabel
Rapid regulation of PDE-2 and ...... elective inhibitors erythro-9-
@nl
Rapid regulation of PDE-2 and ...... )-adenine (EHNA) and rolipram.
@en
P50
P1433
P1476
Rapid regulation of PDE-2 and ...... l)-adenine (EHNA) and rolipram
@en
P2093
P304
P356
10.1016/0898-6568(95)02032-2
P577
1996-02-01T00:00:00Z